119 related articles for article (PubMed ID: 2346541)
1. [Plasma level studies in volunteers after intramuscular injection of various doses of etofenamate in an oily solution].
Beckermann B; Bock E; Kamp R; Dell HD
Arzneimittelforschung; 1990 Mar; 40(3):305-11. PubMed ID: 2346541
[TBL] [Abstract][Full Text] [Related]
2. [Animal experimental evidence of the long-lasting efficacy of etofenamate by prolongation of the half-life after intramuscular application].
Dell HD; Brons J; Fiedler J; Kamp R; Pelster B
Arzneimittelforschung; 1990 Mar; 40(3):300-5. PubMed ID: 2346540
[TBL] [Abstract][Full Text] [Related]
3. [Renal elimination and metabolism of etofenamate in volunteers after administration of various doses].
Dell HD; Beckermann B; Fiedler J; Kamp R
Arzneimittelforschung; 1990 Mar; 40(3):311-6. PubMed ID: 2346542
[TBL] [Abstract][Full Text] [Related]
4. [Plasma- and tissue concentrations following intramuscular administration of etofenamat. Pharmacokinetics of etofenamat and flufenamic acid in plasma, synovium, and tissues of patients with chronic polyarthritis after administration of an oily solution of etofenamat].
Köhler G; Tressel W; Dell HD; Doersing M; Fischer W; Kamp R; Langer M; Richter B; Wirzbach E
Arzneimittelforschung; 1992 Dec; 42(12):1487-91. PubMed ID: 1288513
[TBL] [Abstract][Full Text] [Related]
5. [Anti-inflammatory and analgesic activity of etofenamate after intramuscular injection in laboratory animals].
Pelster B; Dell HD
Arzneimittelforschung; 1990 Mar; 40(3):297-300. PubMed ID: 2346539
[TBL] [Abstract][Full Text] [Related]
6. [Gas-liquid chromatographic determination of etofenamate/ Determination, method and use in biological material (author's transl)].
Dell HD; Fiedler J; Jacobi H; Kolle J
Arzneimittelforschung; 1981; 31(1):17-21. PubMed ID: 6971109
[TBL] [Abstract][Full Text] [Related]
7. Plasma pharmacokinetics of cinmetacin following oral administration in healthy volunteers.
Danesi R; Ducci M; Acerbi D; Del Tacca M
Arzneimittelforschung; 1988 Jan; 38(1):129-31. PubMed ID: 3259136
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of Transdermal Etofenamate and Diclofenac in Healthy Volunteers.
Drago S; Imboden R; Schlatter P; Buylaert M; Krähenbühl S; Drewe J
Basic Clin Pharmacol Toxicol; 2017 Nov; 121(5):423-429. PubMed ID: 28561421
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and bioavailability of nimesulide in goats.
Rao GS; Malik JK; Siddaraju VB; Shankaramurthy NC
J Vet Pharmacol Ther; 2007 Apr; 30(2):157-62. PubMed ID: 17348902
[TBL] [Abstract][Full Text] [Related]
10. Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus.
von Nicolai H; Brickl R; Eschey H; Greischel A; Heinzel G; König E; Limmer J; Rupprecht E
Arzneimittelforschung; 1997 Mar; 47(3):247-52. PubMed ID: 9105542
[TBL] [Abstract][Full Text] [Related]
11. [Studies on metabolism and elimination of etofenamate by dogs (author's transl)].
Dell HD; Jacobi H; Kamp R; Kolle J
Arzneimittelforschung; 1981; 31(1):21-6. PubMed ID: 6971110
[TBL] [Abstract][Full Text] [Related]
12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
13. Analytical determination and pharmacokinetics of robenacoxib in the dog.
Jung M; Lees P; Seewald W; King JN
J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
[TBL] [Abstract][Full Text] [Related]
14. [Anti-inflammatory, analgesic and anti-pyretic activities of a non-steroidal anti-inflammatory drug, etofenamate, in experimental animals].
Nakamura H; Motoyoshi S; Imazu C; Ishii K; Yokoyama Y; Seto Y; Kadokawa T; Shimizu M
Nihon Yakurigaku Zasshi; 1982 Aug; 80(2):125-35. PubMed ID: 6983482
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
Smith WB; Dowell JA; Pratt RD
Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
[TBL] [Abstract][Full Text] [Related]
16. [Metabolism of etofenamate / Identification and analytic of metabolites, their pharmacological properties and species dependence of metabolism (author's transl)].
Dell HD; Doersing M; Fischer W; Fiedler J; Jacobi H; Kamp R
Arzneimittelforschung; 1981; 31(1):9-16. PubMed ID: 6971113
[TBL] [Abstract][Full Text] [Related]
17. Etofenamate levels in human serum and synovial fluid following iontophoresis.
Bender T; Bariska J; Rojkovich B; Bálint G
Arzneimittelforschung; 2001; 51(6):489-92. PubMed ID: 11455681
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of flufenamic acid in man.
Lentjes EG; van Ginneken CA
Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):185-7. PubMed ID: 3583467
[TBL] [Abstract][Full Text] [Related]
19. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M
Chirality; 1997; 9(3):297-302. PubMed ID: 9176996
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacology and toxicology of etofenamate. 2].
Jacobi H; Dell HD; Lorenz D
Arzneimittelforschung; 1977; 27(6B):1333-40. PubMed ID: 579123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
